Barclays PLC Denali Therapeutics Inc. Transaction History

Barclays PLC

$327 Billion
Q2 2024

A detailed history of Barclays PLC transactions in Denali Therapeutics Inc. stock. As of the latest transaction made, Barclays PLC holds 127,060 shares of DNLI stock, worth $3.41 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

127,060

Previous 151,560 16.17%

Holding current value

$3.41 Million

Previous $3.11 Million 5.08%

% of portfolio

0.0%

Previous 0.0%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$14.96 - $23.22 $366,520 - $568,890	-24,500 Reduced 16.17%	127,060 $2.95 Million
Q1 2024 May 15, 2024	SELL	$15.83 - $23.35 $2.73 Million - $4.03 Million	-172,459 Reduced 53.22%	151,560 $3.11 Million
Q4 2023 Feb 15, 2024	BUY	$16.2 - $23.18 $2.55 Million - $3.65 Million	157,512 Added 94.6%	324,019 $6.95 Million
Q3 2023 Nov 07, 2023	BUY	$20.63 - $30.17 $165,968 - $242,717	8,045 Added 5.08%	166,507 $3.44 Million
Q2 2023 Aug 03, 2023	SELL	$23.37 - $32.96 $11.6 Million - $16.4 Million	-497,965 Reduced 75.86%	158,462 $4.68 Million
Q1 2023 May 04, 2023	BUY	$21.91 - $32.67 $1.54 Million - $2.3 Million	70,462 Added 12.02%	656,427 $15.1 Million
Q4 2022 Feb 13, 2023	BUY	$26.28 - $33.92 $6.85 Million - $8.84 Million	260,498 Added 80.04%	585,965 $16.3 Million
Q3 2022 Nov 03, 2022	SELL	$25.97 - $38.53 $1.12 Million - $1.67 Million	-43,304 Reduced 11.74%	325,467 $9.99 Million
Q2 2022 Aug 12, 2022	BUY	$20.88 - $35.19 $6.49 Million - $10.9 Million	310,639 Added 534.37%	368,771 $10.9 Million
Q1 2022 May 16, 2022	SELL	$29.0 - $47.27 $1.82 Million - $2.96 Million	-62,689 Reduced 51.89%	58,132 $1.87 Million
Q4 2021 Feb 14, 2022	BUY	$42.59 - $55.02 $2.12 Million - $2.74 Million	49,856 Added 70.25%	120,821 $5.39 Million
Q3 2021 Nov 09, 2021	BUY	$48.48 - $78.23 $2.29 Million - $3.69 Million	47,204 Added 198.66%	70,965 $3.58 Million
Q2 2021 Aug 13, 2021	SELL	$50.3 - $78.44 $3.32 Million - $5.18 Million	-66,012 Reduced 73.53%	23,761 $1.87 Million
Q1 2021 May 13, 2021	BUY	$53.8 - $81.53 $3.62 Million - $5.49 Million	67,315 Added 299.74%	89,773 $5.13 Million
Q4 2020 Feb 11, 2021	SELL	$36.89 - $93.56 $234,472 - $594,667	-6,356 Reduced 22.06%	22,458 $1.88 Million
Q3 2020 Nov 12, 2020	SELL	$23.13 - $38.84 $156,705 - $263,141	-6,775 Reduced 19.04%	28,814 $1.03 Million
Q2 2020 Aug 12, 2020	BUY	$16.01 - $28.82 $282,080 - $507,779	17,619 Added 98.05%	35,589 $860,000
Q1 2020 May 13, 2020	SELL	$14.2 - $27.98 $435,911 - $858,930	-30,698 Reduced 63.08%	17,970 $314,000
Q4 2019 Feb 10, 2020	BUY	$14.4 - $19.99 $60,739 - $84,317	4,218 Added 9.49%	48,668 $848,000
Q3 2019 Nov 14, 2019	BUY	$15.32 - $21.92 $207,402 - $296,752	13,538 Added 43.8%	44,450 $681,000
Q2 2019 Aug 14, 2019	BUY	$18.5 - $28.14 $317,904 - $483,557	17,184 Added 125.17%	30,912 $642,000
Q1 2019 May 15, 2019	BUY	$17.99 - $24.65 $246,966 - $338,395	13,728 New	13,728 $319,000
Q4 2018 Feb 14, 2019	SELL	$13.88 - $21.75 $236,945 - $371,294	-17,071 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$12.46 - $21.74 $197,279 - $344,209	15,833 Added 1278.92%	17,071 $371,000
Q2 2018 Aug 14, 2018	SELL	$15.25 - $21.02 $32,009 - $44,120	-2,099 Reduced 62.9%	1,238 $19,000
Q1 2018 May 15, 2018	BUY	$15.36 - $24.8 $51,256 - $82,757	3,337 New	3,337 $65,000

Others Institutions Holding DNLI

# of Institutions

216

Shares Held

115M

Call Options Held

127K

Put Options Held

38.3K

View Full List

About Denali Therapeutics Inc.

Ticker DNLI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 134,174,000
Market Cap $3.6B
Description
Denali Therapeutics Inc., a biopharmaceutical company, discovers and develops therapeutic candidates for neurodegenerative diseases in the United States. It offers leucine-rich repeat kinase 2 (LRRK2) inhibitor product candidate, including BIIB122/DNL151, a small molecule inhibitor, which is in phase I and phase Ib clinical trials for the treatm...

More about DNLI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.

Account